Board of Directors
Born in 1972. PhD and Professor in the Division of Materials Science at Uppsala University. Engqvist has over 20 years of experience in the biomaterials industry, is the author of more than 250 scientific articles, and co-inventor of over 60 patent families. He is also a serial entrepreneur and co-founder of OssDsign AB and Emplicure AB.
Other current board assignments: Aduro Material AB, Lea Cares AB, Viaton AB, and OssDsign AB.
Born in 1964. Law graduate from Lund University with specialization in business law. Dahlberg has worked as a lawyer and CEO across several industries and company stages, and has extensive experience as board member and chairman in entrepreneurial ventures.
Other current board assignments: Biomatcell AB, GU Project Accelerator AB, Kaponjären AB, Nanolyze AB, Salinity AB, Salinity Development AB, Brain Biomarker Solutions AB, Personcentrering i Göteborg AB, Salinity Group AB, Salinity Trading AB, Saltwell AB, and Transmed Gothenburg AB.
Born in 1953. M.D. from Karolinska Institutet and PhD from Uppsala University. Former Vice President at Pharmacia Corp and Schering-Plough Inc, where he was responsible for the market approval of multiple pharmaceuticals that reached multi-billion annual sales. He was also a partner at the venture capital firm 3i. Pollare has long experience from board positions in startups, listed companies, and private equity investments.
Other current board assignments: Oncolution AB, AC Intressenter AB, Sinfonia Biotherapeutics AB, Alzecure Pharma AB, Alzecure Discovery AB, Stiftelsen Alzecure, and Premalux AB.
Born in 1955. Dentist educated at Karolinska Institutet with broad experience from both public and private dental care. His career includes roles as dentist, clinic manager within Folktandvården, private clinic owner within Praktikertjänst, referral dentist, assessor at the County Council’s dental office, radiology instructor, and secretary of the Private Dentistry Board in Uppsala County.
Other current board assignments: None.
Born in 1958. M.D. from India and PhD from Karolinska Institutet (1994). Senior Scientist at the Department of Medicine, Karolinska Institutet, affiliated with the Center for Molecular Medicine, Karolinska University Hospital. Former Vice Chancellor of Sri Sathya Sai Institute of Higher Learning (India, 2019–2022) and Scientific Coordinator for India at Karolinska Institutet (1999–2012).
Other current board and advisory roles: Seraxis (USA), Diamyd AB, HBM Ventures (Zug), and Eir Ventures (Stockholm). Previous assignments include Senior Advisor to Business Sweden (2006–2015). Recipient of the Pravasi Bharatiya Samman Award (2017), the highest recognition by the Government of India for persons of Indian origin. Extensively published in peer-reviewed journals and editor of five volumes of Annals of the New York Academy of Sciences on “Immunology of Diabetes.”
